Dictionary and translator for handheld
New : sensagent is now available on your handheld
A windows (pop-into) of information (full-content of Sensagent) triggered by double-clicking any word on your webpage. Give contextual explanation and translation from your sites !
With a SensagentBox, visitors to your site can access reliable information on over 5 million pages provided by Sensagent.com. Choose the design that fits your site.
Improve your site content
Add new content to your site from Sensagent by XML.
Crawl products or adds
Get XML access to reach the best products.
Index images and define metadata
Get XML access to fix the meaning of your metadata.
Please, email us to describe your idea.
Lettris is a curious tetris-clone game where all the bricks have the same square shape but different content. Each square carries a letter. To make squares disappear and save space for other squares you have to assemble English words (left, right, up, down) from the falling squares.
Boggle gives you 3 minutes to find as many words (3 letters or more) as you can in a grid of 16 letters. You can also try the grid of 16 letters. Letters must be adjacent and longer words score better. See if you can get into the grid Hall of Fame !
Change the target language to find translations.
Tips: browse the semantic fields (see From ideas to words) in two languages to learn more.
1.(pregnancy) extraction by centesis of amniotic fluid from a pregnant woman (after the 15th week of pregnancy) to aid in the diagnosis of fetal abnormalities
1.(MeSH)Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions.
Antenatal screening Z36[Classe]
Diagnostic Technic, Obstetrical and Gynecological, Diagnostic Technic, Obstetric and Gynecologic, Diagnostic Technics, Obstetrical and Gynecological, Diagnostic Technics, Obstetric and Gynecologic, Diagnostic Technique, Obstetrical and Gynecological, Diagnostic Technique, Obstetric and Gynecologic, Diagnostic Techniques, Obstetrical and Gynecological, Diagnostic Techniques, Obstetric and Gynecologic, Obstetrical and Gynecological Diagnostic Technic, Obstetrical and Gynecological Diagnostic Technics, Obstetrical and Gynecological Diagnostic Technique, Obstetrical and Gynecological Diagnostic Techniques, Obstetric and Gynecologic Diagnostic Technic, Obstetric and Gynecologic Diagnostic Technics, Obstetric and Gynecologic Diagnostic Technique, Obstetric and Gynecologic Diagnostic Techniques, Technic, Obstetrical and Gynecological Diagnostic, Technic, Obstetric and Gynecologic Diagnostic, Technics, Obstetrical and Gynecological Diagnostic, Technics, Obstetric and Gynecologic Diagnostic, Technique, Obstetrical and Gynecological Diagnostic, Technique, Obstetric and Gynecologic Diagnostic, Techniques, Obstetrical and Gynecological Diagnostic, Techniques, Obstetric and Gynecologic Diagnostic - Laboratory Technics and Procedures, Laboratory Techniques and Procedures - Micropunctures, Punctures - Procedure, Operative Surgical, Surgical Procedures, Operative[Hyper.]
Diagnosis, Preimplantation, Preimplantation Diagnosis - Cytological Technic, Cytological Technics, Cytological Technique, Cytological Techniques, Cytologic Technics, Technic, Cytological, Technics, Cytological, Technique, Cytological, Techniques, Cytological[Analogie]
Amniocentesis (n.) [MeSH]
action de prendre (fr)[Classe]
action d'enlever (fr)[Classe...]
gestation; pregnancy; maternity[ClasseHyper.]
neuf (fr)[termes liés]
liquide amniotique (fr)[Thème]
Amniocentesis (also referred to as amniotic fluid test or AFT) is a medical procedure used in prenatal diagnosis of chromosomal abnormalities and fetal infections, in which a small amount of amniotic fluid, which contains fetal tissues, is sampled from the amnion or amniotic sac surrounding a developing fetus, and the fetal DNA is examined for genetic abnormalities. This process can be used for prenatal sex discernment and hence this procedure has legal restrictions in some gender-biased countries.
Before the start of the procedure, a local anesthetic can be given to the mother in order to relieve the pain felt during the insertion of the needle used to withdraw the fluid. After the local is in effect, a needle is usually inserted through the mother's abdominal wall, then through the wall of the uterus, and finally into the amniotic sac. With the aid of ultrasound-guidance, a physician punctures the sac in an area away from the fetus and extracts approximately 20 ml of amniotic fluid.
If used for prenatal genetic diagnosis, fetal cells are separated from the extracted sample. The cells are grown in a culture medium, then fixed and stained. Under a microscope the chromosomes are examined for abnormalities. The most common abnormalities detected are Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Turner syndrome (monosomy X). In regard to the fetus, the puncture heals and the amniotic sac replenishes the liquid over the next 24–48 hours.
Early in pregnancy, amniocentesis used for diagnosis of chromosomal and other fetal problems such as:
Amniocentesis can predict fetal lung maturity, which is inversely correlated to the risk of infant respiratory distress syndrome. In pregnancies of greater than 30 weeks, the fetal lung maturity may be tested by sampling the amount of surfactant in the amniotic fluid. Several tests are available that correlate with the production of surfactant. These include the lecithin-sphingomyelin ratio ("L/S ratio"), the presence of phosphatidylglycerol (PG), and more recently, the surfactant/albumin (S/A) ratio. For the L/S ratio, if the result is less than 2:1, the fetal lungs may be surfactant deficient. The presence of PG usually indicates fetal lung maturity. For the S/A ratio, the result is given as mg of surfactant per gm of protein. An S/A ratio <35 indicates immature lungs, between 35-55 is indeterminate, and >55 indicates mature surfactant production(correlates with an L/S ratio of 2.2 or greater).
Amniocentesis can also be used to detect problems such as:
An emerging indication for amniocentesis is in the management of preterm rupture of membranes where measurement of certain amniotic fluid inflammatory markers may be helpful. If amniotic fluid IL-6, a marker of inflammation, is elevated, the fetus is at high risk and delivery should be considered.
Amniocentesis is performed between the 15th and 20th week of pregnancy; performing this test earlier may result in fetal injury. The term "early amniocentesis" is sometimes used to describe use of the process between weeks 11 and 13.
Complications of amniocentesis include preterm labor and delivery, respiratory distress, postural deformities, fetal trauma and alloimmunisation of the mother (rhesus disease). Studies from the 1970s originally estimated the risk of amniocentesis-related miscarriage at around 1 in 200 (0.5%). Three more recent studies from 2000-2006 estimated the procedure-related pregnancy loss at 0.6-0.86%.  A more recent study (2006) has indicated this may actually be much lower, perhaps as low as 1 in 1,600 (0.06%). . Unlike the previous studies, the number in this study only reflects the loss that resulted from amniocentesis complications and excluded the cases when parents decided for an abortion following the test results. In contrast to amniocentesis, the risk of miscarriage from chorionic villus sampling (CVS) is believed to be approximately 1 in 100, although CVS may be done up to four weeks earlier, and may be preferable if the possibility of genetic defects is thought to be higher.
A potential benefit of using amniotic stem cells over those obtained from embryos is that they side-step ethical concerns among pro-life activists by obtaining pluripotent lines of undifferentiated cells without harm to a fetus or destruction of an embryo. These stem cells would also, if used to treat the same individual they came from, sidestep the donor/recipient issue which has so far stymied all attempts to use donor-derived stem cells in therapies.
Artificial heart valves, working tracheas, as well as muscle, fat, bone, heart, neural and liver cells have all been engineered through use of amniotic stem cells. Tissues obtained from amniotic cell lines show promise for patients suffering from congenital diseases/malformations of the heart, liver, lungs, kidneys, and cerebral tissue.